Ionica Sciences logo — Our first test, IonLyme™, specifically addresses Lyme diseas...

Ionica Sciences

Our first test, IonLyme™, specifically addresses Lyme disease, the fastest growing vector borne disease in the USA.

Founded 2013 United States Ithaca, United States 2-10 employees Grant Total: $1.17M Biotechnology, Health Care +1

General Information

Company Name Ionica Sciences
Founded Year 2013
Location United States Ithaca, United States
Founders / Decision Makers
Team member
Employees 2-10
Industries Biotechnology, Health Care, Information Technology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Ionica Sciences. To contact Ionica Sciences, visit ionicasci.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ionica Sciences compare?

A PDF of Ionica Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ionica Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ionica Sciences

Ionica Sciences is a biotechnology startup established in 2013 with a mission to apply spectroscopic approaches to detect biologically relevant targets, including pathogens, hormones, or other disease indicators. The company's first test, IonLyme™, specifically addresses Lyme disease, the fastest-growing vector-borne disease in the USA. The founders, with a combined 40 years of research experience, have expertise in chemistry, vibrational spectroscopy, molecular biology, and biotechnology. Their previous success in winning US federal Small Business Innovative Research (SBIR) grants includes bringing in $30 million in funding from Phase I and Phase II programs. Ionica Sciences is currently focused on a DARPA funded development effort for the detection and quantitation of biologically relevant molecules at pg/ml levels, leveraging the company’s spectroscopic and biotechnological expertise. Additionally, the startup is collaborating with researchers in biological detection and spectroscopic methodologies at Cornell University and the City College of New York. The latest investment of $255.47K grant was received on 30 November 2020 from the National Science Foundation. Combining cutting-edge technology with extensive research experience, Ionica Sciences anticipates bringing an FDA-approved assay to market within 3-5 years, offering inexpensive assays for use in point-of-care settings without the need for lengthy preparation times or extensive instrumentation. This innovative approach and strategic collaborations position Ionica Sciences as a promising player in the biotechnology and healthcare industries.

Business keywords: Diagnostics Development, Raman Spectroscopy, Aptamer Development, Platform Technologies, Point of Care Testing, Clinical Diagnostics, Spectroscopic Approaches, Biological Detection, Chemical Detection, Infectious Disease, Healthcare Innovation, SBIR Grants, FDA Approval, Vector Borne Disease

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $255.47K 1
National Science Foundation
30 Nov 2020
Grant $35.00K 1
FuzeHub
03 Sep 2019
Convertible Note $225.00K 1
Launch NY
01 Oct 2018
Grant $150.00K 1
U.S. Department of Defense
19 Feb 2018
Pre Seed Round $178.00K -
10 Oct 2017
Grant $25.00K 1
CenterState CEO
27 Aug 2015
Grant $149.99K 1
U.S. Department of Defense
02 Dec 2014
Angel Round Undisclosed 1
Boston Harbor Angels
01 Jan 2014
Grant $148.16K 1
U.S. Department of Defense
29 Oct 2013

Ionica Sciences Alternatives & Competitors

View All Alternatives
Ionica Sciences vs

Specializing in Testing for Flea- and Tick-borne Diseases

Seed
17 employees
Biotechnology, Health Care
Ionica Sciences vs
SomaScan
SomaScan United States

Transforming research and healthcare with industry-leading proteomics

Post-IPO Equity
143 employees
Biotechnology, Health Care
Ionica Sciences vs

Empowering clinicians with rapid, near-patient molecular testing for improved patient care and reduc...

Series B
Biotechnology, Health Care

FAQ About Ionica Sciences

Our first test, IonLyme™, specifically addresses Lyme disease, the fastest growing vector borne disease in the USA.
Ionica Sciences was founded in 2013.
Ionica Sciences is headquartered in Ithaca, United States.
Ionica Sciences operates in Biotechnology, Health Care and Information Technology. Its work centres on Diagnostics Development, Raman Spectroscopy, Aptamer Development and Platform Technologies.
Ionica Sciences has approximately 2-10 employees.
Ionica Sciences has completed 9 funding rounds, raising a total of $1.17M. The latest funding stage is Grant.
Top alternatives and competitors to Ionica Sciences include Galaxy Diagnostics, Inc., SomaScan, Xagenic, EMPE Diagnostics, STAT-Dx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ionica Sciences and Galaxy Diagnostics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ionica Sciences, https://bouncewatch.com/company/ionica-sciences, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes